DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriTeQ Acquisition Corporation (“VeriTeQ” or “Company”), a leader in implantable, radio frequency identification (“RFID”) for humans and animals, announced today it will offer its FDA-cleared VeriChip microchip, a rice grain-sized, passive RFID microchip, for the identification of breast implants and other medical devices. VeriTeQ is already working to identify medical devices, specifically vascular ports, for the proper identification of the port and medication dosing requirements through an existing contract with a medical device manufacturer.
